General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Amgen(SIGNIFICANT), Merck & Co., Inc.(SIGNIFICANT), Boehringer Ingelheim Pharmaceuticals, Inc(SIGNIFICANT), Urovant Pharmaceuticals(MODEST), PhamaIN(SIGNIFICANT), AstraZeneca Pharmaceuticals(SIGNIFICANT), CSL Vifor(SIGNIFICANT), Sanofi(SIGNIFICANT), Cytokinetics(SIGNIFICANT), Roche Diagnostics(SIGNIFICANT), Tricog Health(SIGNIFICANT), Lexicon(SIGNIFICANT), Bayer Healthcare Pharmaceuticals(SIGNIFICANT), scPharmaceuticals(SIGNIFICANT) RESEARCH/RESEARCH GRANTS: Bristol-Myers Squibb(NONE), AstraZeneca Pharmaceuticals(NONE), Novartis Corporation(SIGNIFICANT), Pfizer(SIGNIFICANT), Bristol-Myers Squibb Company (SIGNIFICANT), Novartis Corporation(SIGNIFICANT)

View Full Disclosure